Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 7/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 6/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.37 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.37 |
| ▸ | GALR3 | O60755 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28453108 | 0.85 | ADRA2A (0.35) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL3518545 | 0.83 | THRB (0.43) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL28355454 | 0.80 | CHRM1 (0.40) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL6293186 | 0.79 | CHRM1 (0.35) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL28508063 | 0.79 | CHRM1 (0.35) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL3504552 | 0.79 | ADRA2A (0.37) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL17076360 | 0.74 | CHRM5 (0.33) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL28041832 | 0.74 | CHRM1 (0.41) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL2022215 | 0.74 | CHRM5 (0.41) | CHRM1CHRM5CHRM3CHRM2CHRM4 | |
| SCHEMBL28800739 | 0.72 | TSHR (0.41) | CHRM1CHRM5CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021030-A1 | FRAGRANCE-CONTAINING MICROPARTICLES | GIVAUDAN SA (CH) | 2026-01-22 | — | — | US | claimed |
| EP-3132810-B1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2025-10-29 | — | — | EP | claimed |
| US-11925547-B2 | Prosthesis for in vivo insertion, coated with cross-linked polyphosphorylcholine | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-03-12 | — | — | US | claimed |
| CN-116265033-A | Long-acting anticoagulation coating and plasma preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2023-06-20 | — | — | CN | claimed |
| WO-2023000713-A1 | STRONG-ADHESIVE POLYELECTROLYTE HYDROGEL COATING AND PREPARATION METHOD THEREFOR | 浙江大学 | 2023-01-26 | — | — | WO | claimed |
| US-20210378814-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2021-12-09 | — | — | US | claimed |
| EP-3515993-B1 | METHOD FOR PRODUCING A WATER-SOLUBLE THERMALLY-CROSSLINKABLE POLYMERIC MATERIAL | ALCON INC (CH) | 2021-11-10 | — | — | EP | claimed |
| US-11129706-B2 | Prosthesis for in vivo insertion, coated with cross-linked polyphosphorylcholine | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-09-28 | — | — | US | claimed |
| CN-109265512-B | Preparation method of protein conjugate based on pyridine dicarbaldehyde | 清华大学 | 2021-06-11 | — | — | CN | claimed |
| EP-2988790-B1 | BIOACTIVE COATINGS | BIOINTERACTIONS LTD (GB) | 2021-04-28 | — | — | EP | claimed |
| EP-2723752-B1 | BIOCOMPATIBLE, BIOMIMETIC AMPHOLYTE MATERIALS | BIOINTERACTIONS LTD (GB) | 2020-08-05 | — | — | EP | claimed |
| EP-2644188-B1 | OIL-IN-WATER-TYPE EMULSION SKIN COSMETIC | SHISEIDO CO LTD (JP) | 2018-09-26 | — | — | EP | claimed |
| US-20180127529-A1 | Water-Absorbing (Meth) Acrylic Resin With Optical Effects, And Related Compositions | ELC MAN LLC (US) | 2018-05-10 | — | — | US | claimed |
| EP-3132810-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS-LINKED POLYPHOSPHORYLCHOLINE | Seoul National University R&DB Foundation (KR) | 2017-02-22 | — | — | EP | claimed |
| US-20170035555-A1 | PROSTHESIS FOR IN VIVO INSERTION, COATED WITH CROSS- LINKED POLYPHOSPHORYLCHOLINE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2017-02-09 | — | — | US | claimed |
| JP-9315935-A | — | — | None | — | — | JP | disclosed |
| JP-6157269-A | — | — | None | — | — | JP | disclosed |
| JP-H09315935-A | IRRITANCY-SUPPRESSIVE COSMETIC | POLA CHEM IND INC | 1997-12-09 | — | — | JP | disclosed |
| JP-H06157269-A | COSMETIC | POLA CHEM IND INC | 1994-06-03 | — | — | JP | disclosed |
| JP-H0339309-A | 2-METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE COPOLYMER | RES DEV CORP OF JAPAN | 1991-02-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127529-A1 | Water-Absorbing (Meth) Acrylic Resin With Optical Effects, And Related Compositions | MMAB, ASIC1, MAT1A | CHRM1 2719/4885CHRM5 2767/4885CHRM3 3181/4885 |
| US-20260021030-A1 | FRAGRANCE-CONTAINING MICROPARTICLES | SGMS2, SGMS1, PHOSPHO1 | CHRM1 912/4885CHRM5 251/4885CHRM3 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.